Korro Bio, Inc.(KRRO)

Biotechnology · Cambridge, MA

$9.65-0.32 (-3.21%)

Delayed quote: Oct 6, 2026, 10:05 AM EDT

EV/EBIT Ratio: N/A

Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.

The EV/EBIT ratio is N/A as of 2026-10-06T14:07:13.946Z.

Stored calculation inputs

Calculation as of: 2026-10-06T14:07:13.946Z.

Quote observation: 2026-10-06T14:05:14.000Z. Amounts in USD. The price header may show a later quote.

Quote market capitalization: 96,049,992
Total debt · period ending 2026-06-30: 42,213,000
Cash · period ending 2026-06-30: 24,905,000
TTM operating income · period ending 2026-06-30: -75,666,000

FMP input reference: eea6c7d5cd6e3fe508f4e89a8ac0afa25f3437e05bd10ab9ad2dfceb562d4ef8

EV/EBITDA|EV/Sales|Operating Income|All Metrics

Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.

KRRO EV/EBIT Ratio Metrics

EV/EBIT RATIO

N/A

KRRO Competitors' EV/EBIT Ratio

KRRO

Korro Bio, Inc.

Current

Market Cap

$96.05M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

MIST

Milestone Pharmaceuticals Inc.

vs KRRO

Market Cap

$98.00M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ANIX

Anixa Biosciences, Inc.

vs KRRO

Market Cap

$98.16M

EV/EBIT Ratio

N/A

TTM Avg

28.81x

3Y Avg

28.81x

5Y Avg

28.81x

BMEA

Biomea Fusion, Inc.

vs KRRO

Market Cap

$91.82M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

ECOR

electroCore, Inc.

vs KRRO

Market Cap

$92.14M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

Equillium, Inc.

vs KRRO

Market Cap

$90.41M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

JYNT

The Joint Corp.

vs KRRO

Market Cap

$102.35M

EV/EBIT Ratio

57.30x

TTM Avg

89.36x

3Y Avg

94.92x

5Y Avg

1303.85x

ICCC

ImmuCell Corporation

vs KRRO

Market Cap

$88.21M

EV/EBIT Ratio

23.74x

TTM Avg

34.08x

3Y Avg

34.41x

5Y Avg

73.74x

CCLD

CareCloud, Inc.

vs KRRO

Market Cap

$87.75M

EV/EBIT Ratio

13.65x

TTM Avg

11.03x

3Y Avg

8.69x

5Y Avg

166.50x

CRDF

Cardiff Oncology, Inc.

vs KRRO

Market Cap

$87.48M

EV/EBIT Ratio

N/A

TTM Avg

N/A

3Y Avg

N/A

5Y Avg

N/A

NAME	MARKET CAP	EV/EBIT RATIO	TTM	3Y	5Y
Korro Bio, Inc. (KRRO)	$96.05M	N/A	N/A	N/A	N/A
Milestone Pharmaceuticals Inc. (MIST)vs ›	$98.00M	N/A	N/A	N/A	N/A
Anixa Biosciences, Inc. (ANIX)vs ›	$98.16M	N/A	28.81x	28.81x	28.81x
Biomea Fusion, Inc. (BMEA)vs ›	$91.82M	N/A	N/A	N/A	N/A
electroCore, Inc. (ECOR)vs ›	$92.14M	N/A	N/A	N/A	N/A
Equillium, Inc. (EQ)vs ›	$90.41M	N/A	N/A	N/A	N/A
The Joint Corp. (JYNT)vs ›	$102.35M	57.30x	89.36x	94.92x	1303.85x
ImmuCell Corporation (ICCC)vs ›	$88.21M	23.74x	34.08x	34.41x	73.74x
CareCloud, Inc. (CCLD)vs ›	$87.75M	13.65x	11.03x	8.69x	166.50x
Cardiff Oncology, Inc. (CRDF)vs ›	$87.48M	N/A	N/A	N/A	N/A

EV/EBIT Ratio Formula & Definition

EV/EBIT = Enterprise Value / EBIT (TTM)

Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.

Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute

EV/EBIT Ratio: N/A

KRRO EV/EBIT Ratio Metrics

KRRO Competitors' EV/EBIT Ratio

EV/EBIT Ratio Formula & Definition

Related Metrics